Clinical Trial Update: Proof-of-Concept Superiority Trial of Fosravuconazole Versus Itraconazole for Eumycetoma in Sudan [Phase 2]

View source ↗

Summary

A Phase 2 proof-of-concept trial in Sudan compared fosravuconazole to itraconazole for eumycetoma and has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Mycetoma

Drugs mentioned

• Fosravuconazole (fosravuconazole)
• Itraconazole (Itraconazole)

Snippet

Sponsor: Drugs for Neglected Diseases | Conditions: Mycetoma | Phase 2 | Status: COMPLETED